Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Prepaid Assets (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Prepaid Assets for 14 consecutive years, with $441489.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Prepaid Assets fell 40.0% year-over-year to $441489.0, compared with a TTM value of $441489.0 through Sep 2025, down 40.0%, and an annual FY2024 reading of $1.1 million, up 264.88% over the prior year.
  • Prepaid Assets was $441489.0 for Q3 2025 at Sunshine Biopharma, down from $939436.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.8 million in Q2 2024 and bottomed at $10993.0 in Q1 2021.
  • Average Prepaid Assets over 5 years is $419399.4, with a median of $152262.0 recorded in 2023.
  • The sharpest move saw Prepaid Assets surged 1859.2% in 2024, then plummeted 47.12% in 2025.
  • Year by year, Prepaid Assets stood at $29625.0 in 2021, then surged by 857.97% to $283799.0 in 2022, then rose by 9.44% to $310591.0 in 2023, then soared by 264.88% to $1.1 million in 2024, then plummeted by 61.04% to $441489.0 in 2025.
  • Business Quant data shows Prepaid Assets for SBFM at $441489.0 in Q3 2025, $939436.0 in Q2 2025, and $983536.0 in Q1 2025.